PLUR
Pluri Inc
NASDAQ · Biotechnology
$3.47
-0.18 (-4.93%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.78M | 4.21M | 5.36M |
| Net Income | -89,322 | -76,163 | -75,826 |
| EPS | — | — | — |
| Profit Margin | -1.9% | -1.8% | -1.4% |
| Rev Growth | +18.6% | +17.4% | +13.4% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 12.04M | 10.60M | 10.10M |
| Total Equity | 12.52M | 12.82M | 11.60M |
| D/E Ratio | 0.96 | 0.83 | 0.87 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | -95,763 | -73,642 | -95,229 |
| Free Cash Flow | -44,479 | -41,548 | -57,067 |